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Abstract. The creation of entirely synthetically derived bone 
substitute materials which are as effective as autologous bone 
grafts is desirable. Osteogenesis involves the concerted action 
of several proteins within a signaling cascade. Hedgehog 
proteins act upstream of this cascade, inducing the expression 
of various bone morphogenetic proteins (BMPs) and promoting 
physiological bone healing. Therefore, the hypothesis that 
hedgehog signaling in bone defects improves bone healing 
more than BMP signaling alone was tested. Recombinant 
N-terminal sonic hedgehog protein (N-SHh), BMP-2 or a 
combination of the two was added to β-tricalcium phosphate 
(β-TCP) and 5-mm femoral midshaft defects in nude rats were 
filled with these composites. The defects were stabilized with 
mini‑plates. After eight weeks, the animals were sacrificed and 
the femora were explanted. The radiological evaluation was 
followed by a three-point bending test and histological exami-
nation. BMP-2/β-TCP composites showed a trend of increased 
stiffness compared with the controls (β-TCP without protein). 
N-SHh/β-TCP composites had lower stiffness compared with 
the control group and the N-SHh/BMP-2/β-TCP compos-
ites also had lower average stiffness compared with the 
controls (all not significant). Histomorphometry, however, 
revealed abundant cartilage and bone core formation in the 
N-SHh-composite groups. The sum of the new cartilage and 
bone was highest in the combination group N-SHh/BMP-2 
(not significant). The addition of N-SHh to bone substitute 
materials appears to delay bone healing at the applied concen-
tration and observation time but also showed a trend for higher 
amounts of ossifying cartilage. 
Introduction
Hedgehog proteins are crucial in the embryonic develop-
ment of animals, from insects to mammals (1). Furthermore, 
hedgehog proteins are postnatally involved in physiological 
bone growth as well as in fracture healing (2-4). In vitro, 
sonic hedgehog protein (SHh) causes the proliferation and 
differentiation of mesenchymal stem cells into the osteo-
blastic lineage by upregulating bone morphogenetic proteins 
(BMPs) via SMAD signaling (5). Previous studies have 
shown that the combination of recombinant N-terminal SHh 
(N-SHh) with BMP-2 synergistically induces the expres-
sion of osteogenic markers in progenitor cells, whereas the 
transplantation of N-SHh into the muscles of mice failed to 
induce ectopic bone formation after two weeks (6). In turn, 
the implantation of dermal fibroblasts expressing hedgehog 
proteins into nude mice induced ectopic bone formation (7). 
The mechanism for hedgehog proteins in bone formation 
in vivo remains unclear.
The expression of SHh by transduced fibroblasts appears 
to be a reliable method for inducing ectopic bone formation, 
since a further study demonstrated the closure of calvarial 
bone defects in rabbits using SHh‑expressing fibroblasts (8). 
However, in clinical practice, the use of genetically modified 
cells does not yet appear to be adequate. Instead, the appli-
cation of osteoinductive proteins to porous synthetic bone 
substitute materials is a promising approach. 
Based on past experience, a combination of BMPs with 
β-tricalcium phosphate (β-TCP), a bone substitute material, 
works synergistically to yield new bone in animals (9) and has 
good release properties, as well as inducing higher amounts 
of bone formation than are obtained with a combination of 
BMP-2 and hydroxyapatite (10).
The application of BMP-2 to bone defects in humans is 
already used in clinical practice. However, the benefit is 
not clear and adverse reactions, including infection, pain, 
heterotopic bone formation and immunogenic reactions, may 
be observed (11). One explanation for this limitation is that 
BMP-2 as a monotherapy requires higher concentrations to 
work than are required in physiological bone healing. 
We hypothesized that the application of commercially 
available N-SHh protein (alone or in combination with 
BMP-2) to β-TCP would induce osteogenesis in bone defects 
in a superior manner to a combination of β-TCP and BMP-2. 
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Materials and methods
Scaffold preparation
Scaffold. β-TCP is one of the most commonly used materials 
for bone tissue engineering and it has osteoconductive proper-
ties (12). β-TCP is completely biodegraded over a period of up to 
two years, depending on the host's metabolism (13). β-TCP bodies 
for small animal studies (chronOS; granule size, 0.7‑1.4 mm) 
were obtained from Synthes (Dübendorf, Switzerland). The 
bodies had a porosity of ~60%. The macropores had a diameter 
of ~100-500 µm and the micropores were <5 µm. The weight 
of 0.5 cc chronOS (0.7-1.4 mm) was ~0.5 g. Mesenchymal stem 
cells adhered favourably to chronOS in vitro (14).
BMP‑2. Recombinant human BMP was purchased from 
R&D Systems (Wiesbaden, Germany). The human protein was 
used since BMPs are highly conserved across animal species. 
In particular, mature human, mouse and rat BMP-2 are 100% 
identical at the amino acid sequence level.
SHh. Recombinant human N-SHh was also obtained from 
R&D Systems. SHh proteins are highly conserved at the 
N-terminus across vertebrates (99%) and studies support that 
they are also conserved in their functional properties (15).
Composite preparation. The BMP-2 and N-SHh were 
dissolved in phosphate-buffered saline, yielding a stock 
solution comprising 20 µg/ml BMP-2 and 50 µg/ml N-SHh. 
According to the literature, these concentrations are only 
marginally effective and thus were suited to examining 
whether a synergistic effect was observed. 
Next, the β-TCP was soaked with this solution. The soaked 
β-TCP was dried under a hood overnight, then packaged in 50 µg 
(i.e. 2.5 µg N-SHh and/or 1 µg BMP-2) portions. These portions 
were stored at ‑20˚C until use. Previous studies have shown that 
these preparations retain their osteoinductive activity (9,10).
Surgical procedure
Animals. For the critical‑sized defect model athymic nude rats 
(RH-Foxn1
rnu) were used so that immunological reactions to 
the human N-SHh were entirely excluded. The animals were 
purchased from Harlan Laboratories (Harlan Winkelmann 
GmbH, Kreuzelweg, NM Horst, The Netherlands) This animal 
model is T‑cell deficient but has normal B‑cell function.
The animals were divided into four groups (Table I). The 
first group served as a control and the critical‑sized femoral 
defects in this group were filled only with inorganic bone 
substitute material (β-TCP). The second group was a test 
group. The femoral defects of these animals were filled with 
β-TCP combined with N-SHh. The third group also served as 
a test group and the femoral defects were filled with β-TCP 
impregnated with N-SHh and BMP-2. In the fourth group, the 
defects were filled with β-TCP and BMP-2. 
Surgery. Under general anesthesia (ketamine/xylazine i.p.) 
and aseptic conditions, the anterolateral aspect of the right rat 
femur was dissected. A plate was then positioned on the femur 
and fixed with four screws, leaving two holes in the midshaft 
free. Next, the screws and plate were loosened and two 5-mm 
osteotomies of the mid shaft femur were performed with a 
liston-key. A 5-mm empty segmental defect in a rat femur 
does not heal (defined as a critical defect) as demonstrated in 
previous studies (16). The plate was then readapted to the femur 
and the screws were tightened. Protein-impregnated scaffolds 
were implanted into the segmental defects (50 µg each) and 
the wound was closed with absorbable suture material (Fig. 1). 
The animals received metamizole in their drinking water as 
pain treatment over the subsequent days. The rats were housed 
for eight weeks under standard conditions and nutrition.
Osteosynthesis materials. The plates and screws were 
obtained from Synthes (LCP compact hand). The smallest tita-
nium plate (1.0) with twelve non-locking holes was used. The 
plate was cut so that a six-hole-plate was used for each femur. 
The screws were self-cutting and had a diameter of 1.3 mm 
and a length of 6 mm. The decision was made to stabilize the 
critical‑sized defect with a plate rather than an external fixator 
since plates appeared to be more comfortable for the rats and 
also exhibited greater stability (17).
Evaluation
The animals were sacrificed after eight weeks by inhalation 
anesthesia and following i.p. pentobarbital injection. The 
femora were explanted and freed from the ambient tissue. Since 
it was not possible to remove all overgrown plates and screws 
without destroying their structure, the decision was made to 
evaluate all femora complete with the implanted osteosynthesis 
material. Since these small plates were relatively flexible and 
they were all tested under identical conditions, the obtained 
results were considered to be relevant. Following explantation, 
the subjective observations with regard to the stability were 
noted for each femur: stable, unstable or insecure. Next, the 
explantation was followed by conventional radiography. The 
results were rated by two observers as consolidated or not 
consolidated (with regard to uninterrupted callus or not).
Mechanical testing. The bones were stored at ‑20˚C until 
mechanical testing. Mechanical testing was performed by a 
standardized three point bending test using a material testing 
device (Zwicki-line 5.0; Zwick-Roell, Ulm, Germany). The 
thawed bone was placed onto the device to measure the flex-
ural stability in an anterior/posterior direction. The degree of 
displacement in mm at the highest pressure reached was noted. 
From these data the stiffness for each construct was calculated.
Histology. The femoral specimens were collected and 
decalcified in 15% formic acid at 4˚C. After 14 days the 
screws and plates were removed. Following further processing 
the bones were paraffin‑embedded and cut. The slides were 
stained with hematoxylin and eosin. Two observers identified 
Figure 1. Intraoperative site of the critical‑sized defect, stabilized with a 
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the type of tissue adjacent to the defect area. Next, the amounts 
of newly formed cartilage and bone were determined using 
public domain ImageJ software (http://rsb.info.nih.gov/ij/). All 
samples were evaluated three times (same magnification for 
all).
Statistical analysis
Sample size calculation. For determining the sample size, a 
mean stiffness of 15 N/mm was assumed in the control group 
(stabilized defects filled with β-TCP alone) with a standard 
deviation of 10 N/mm (obtained from preliminary results). The 
stiffness was expected to increase to 30 N/mm under treat-
ment with BMP‑2 and SHh. The minimum number of subjects 
required to detect a difference (under standard assumptions, 
α, 0.05; β, 0.80) was therefore eight animals in each group. 
To detect an even smaller difference of 13 N/mm the group 
number was increased to 10 animals. 
Normality testing. The data were first analyzed for normal 
distribution by the D'Agostino-Pearson omnibus normality 
test. The majority of groups did not pass this normality test 
(α, 0.05). For the remaining groups, normality could not be 
assumed due to the small sample size. 
Analysis of variance (ANOVA). The data were then 
analyzed by non‑parametric ANOVA (Kruskal‑Wallis test), 
followed by the pairwise Dunn's multiple comparison test.
Results
Surgery and mechanical testing. The surgical procedures under 
general anesthesia were performed without complications, 
although two rats died during surgery due to major bleeding. 
During follow‑up, three more animals were sacrificed due to 
disabling swelling of the upper leg and nerve injury. Another 
animal had unclear cachexia and was sacrificed. These deceased 
Figure 2. Radiological aspects of femora eight weeks after surgery. From left to right: defect filling with β-TCP/N-SHh, β-TCP/BMP-2 and β-TCP/N-SHh/BMP-2. 
The central femur, filled only with β-TCP/BMP-2 shows an uninterrupted callus-bridge. β-TCP, β-tricalcium phosphate; N-SHh, N-terminal sonic hedgehog 
protein; BMP-2, bone morphogenetic protein.
Figure 3. Graphical representation of the stiffness of the femora explanted 
from rats eight weeks after surgery (n=10 animals per group). Error bars 
indicate the standard deviation. Using the ANOVA Kruskal‑Wallis test, no 
significant differences were observed (P=0.2166). N‑SHh, N‑terminal sonic 
hedgehog protein; BMP‑2, bone morphogenetic protein. ANOVA, analysis 
of variance.
Figure 4. Histomorphometric distribution of newly formed cartilage and 
bone in the four treatment groups, measured with ImageJ. Error bars indicate 
the standard deviation. No mean differences for cartilage and bone were   
observed to be significant; ANOVA Kruskal‑Wallis test; P (bone) = 0.353 and 
P (cartilage) = 0.0978. N‑SHh, N‑terminal sonic hedgehog protein; BMP‑2, 
bone morphogenetic protein; β-TCP, β-tricalcium phosphate; ANOVA, 
analysis of variance.
Table I. Grouping of animals.
Group number  Number of animals  Filling of the femoral critical sized defect
1  10  β-TCP only (bone substitute material)
2 10  β-TCP + N-SHh
3 10  β-TCP + N-SHh + BMP-2
4 10  β-TCP + BMP-2
β-TCP, β-tricalcium phosphate; N-SHh, N-terminal sonic hedgehog protein; BMP-2 bone morphogenetic protein-2.WARZECHA et al: EFFECT OF SONIC HEDGEHOG IN EXPERIMENTAL BONE HEALING 1038
animals were replaced by identically treated animals to main-
tain 10 animals in each group. The remaining animals did well 
and had no signs of impairment during the entire eight weeks.
The first observation of the bones (stable, unstable or inse-
cure) was noted when the femora were explanted. Next, the 
radiological evaluation was performed (Fig. 2). The femora in the 
N-SHh and N-SHh/BMP groups were observed to have healed 
poorly. The femora of the N-SHh and N-SHh/BMP groups 
appeared to be less stable and radiologically consolidated than 
their counterparts with BMP-2 and more so compared with the 
control with only β-TCP and no protein at all (Table II).
When the mechanical testing was performed, this trend was 
observed further. The stiffness was calculated and the femora 
with N-SHh and N-SHh/BMP-2 exhibited the lowest stiffness. 
Femora that were combined with BMP-2 were more than twice 
as stiff as the femora combined with N-SHh (Fig. 3). 
Histomorphometry. The amount of newly formed carti-
lage and bone was calculated by ImageJ and noted as pixels 
per probe (whole defect area, Figs 5 and 6). With regard 
to the formation of new cartilage, the experimental group 
treated with BMP-2 and N-SHh yielded the highest amount 
with 410,034 pixels per sample. The animals with the N-SHh 
constructs had an average of 348,109 pixels per sample. The 
group that served as a negative control (β-TCP only) had an 
average of 221,426 pixels per sample. The BMP-2 group, the 
positive control, had the lowest average with 193,938 pixels 
per sample. 
Newly formed bone was present at the highest levels in 
the group treated with BMP-2 (344,550 pixels per sample), 
followed by the control group (empty) with 291,301 pixels 
per sample. Less bone was observed in the group treated with 
BMP‑2 and N‑SHh (258,509) and the least amount of bone 
was observed in the group treated with N-SHh (231,219). The 
amount of newly formed bone among the groups reflected the 
stiffness trend observed in the mechanical testing (Fig. 4). 
Discussion
Bone defects in humans develop in various situations and 
frequently represent major clinical problems in bone surgery. 
Figure 5. (A and B) Former defect area of an animal treated with an N-SHh/β-TCP composite. Abundant cartilage formation with little bone (arrow). (B) More 
bone is flanked by ossifying cartilage. (C) Defect area of a control animal (only β‑TCP). Arrow indicates new bone adjacent to cartilage. N‑SHh, N‑terminal 
sonic hedgehog protein; β-TCP, β-tricalcium phosphate.
Figure 6. Example of analysis of cartilage formation with ImageJ (50x mag-
nification). The yellow line encloses the measured area.
Table II. Values of clinical (stable), radiological (consolidated) and mechanical examination of the explanted rat femora (± indi-
cates standard deviation). 
 Group
 -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Values  β-TCP  β-TCP + N-SHh  β-TCP + N-SHh + BMP-2  β-TCP + BMP-2
Stable  (%)  60  40 40 60
Consolidated  (%)  50  10 30 50
F max (N)    47.9±28.0   33.0±23.4    38.3±27.0  59.1±7.5
Flexion (mm)    3.2±1.2  3.5 ±1.2    3.4±1.7    3.0±1.5
Stiffness (N/mm)  16.5±8.5   12.3±10.3  13.4±9.7  26.3±2.0
Between the groups and parameters, no significant differences were observed (ANOVA, Kruskal‑Wallis). Not included are the six animals that 
died perioperatively (which were not analyzed but replaced by identically treated rats). β-TCP, β-tricalcium phosphate; N-SHh, N-terminal 
sonic hedgehog protein; BMP‑2, bone morphogenetic protein; ANOVA, analysis of variance.
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The current treatment strategies include autologous bone 
transplantation, allogenous bone transplantation or, for 
smaller defects, filling with inorganic bone substitute mate-
rials. Autologous bone transplantation is typically restricted 
by donor site morbidity, limited amounts of harvested bone 
and longer or more extensive surgical procedures. Allogenous 
bone transplantation has the imminent risk of the transmission 
of infectious diseases and therefore requires laborious and 
expensive preparation procedures.
Synthetic inorganic bone substitutes, such as hydroxy-
apatite or TCP, are widely used and extremely biocompatible, 
particularly TCP which mimics the natural inorganic part of 
bone. The major disadvantage is the lack of osteoinductive 
properties. Therefore, the use of TCP is not adequate for 
diaphyseal or larger metaphyseal bone defects. To overcome 
this, TCP may be augmented by an osteoinductive protein, 
such as BMP-2.
In a rat model, the callus formation and bending strength of 
a TCP + 25 µg rhBMP-2 bone graft was superior to that of an 
autologous bone graft. Thus, TCP/rhBMP-2 composites have 
the potential to become effective substitutes for autologous 
bone grafts (18).
To demonstrate the effect of hedgehog signaling in diaphy-
seal bone defects, N-SHh impregnated β-TCP was implanted 
into critical‑sized femoral defects of athymic rats. The defect 
was stabilized with the smallest available plate normally used 
in hand surgery. β-TCP/BMP-2 composites were used as a 
control. After eight weeks, the animals were sacrificed and 
the explanted femora were evaluated by clinical, radiological, 
biomechanical and histological examinations.
Notably, the N-SHh/β-TCP composites had lower stiff-
ness than the control group consisting of β-TCP without 
any protein application. This effect was also observed in 
the N-SHh/BMP-2/β-TCP composites. The BMP-2/β-TCP 
composites showed the highest stiffness.
The results of the histomorphometrical analysis 
showed the highest amounts of cartilage in the N-SHh and 
N-SHh/BMP-2 groups. In this cartilage, bony islands were 
frequently observed, indicating a current process of endo-
chondral ossification. The sum of the bone and cartilage was 
the highest in the N-SHh/BMP-2 group, which supports our 
initial hypothesis.
In conclusion, the addition of N-SHh at a concentration of 
20 µg/ml delays bone healing when added to bone substitute 
materials, even in combination with BMP-2. However, the 
amount of ossifying cartilage was the highest in the N-SHh 
groups, indicating a potential for robust bone healing. Further 
studies should incorporate longer time spans for an adequate 
healing period.
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